Bimatoprost/Timolol Fixed Combination: A 3-month Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference15 articles.
1. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial;Heijl;Arch Ophthalmol,2002
2. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration;Am J Ophthalmol,2000
3. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002
4. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs;Chrai;J Pharm Sci,1974
5. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?;Robin;Ophthalmology,2005
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficiency and safety of the fixed latanoprost/ dorzolamide combination in open-angle glaucoma hypotensive treatment;Russian Ophthalmological Journal;2023-10-10
2. MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-08-24
3. A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension;Current Medical Research and Opinion;2023-04-17
4. Causal inference for longitudinal data based on historical controls;Journal of Biopharmaceutical Statistics;2022-12-05
5. Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension;Ophthalmology and Therapy;2022-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3